RE: Flat-lined9 Aug 2022 23:08
You know my thoughts on most of those points
BYP. The DHSC dispute may well have happened to any other competitor to shoehorn the favoured few thru the backdoor. Look at Randox who got contract after contract and the connection with the Tory party. Look at ABDX , Nanopore , ODX , we just unfortunately have been shafted for a much larger amt and DHSC obviously intend to string it out. I believe we will win.
Re Ajan , there is no proof what so ever that what was printed was true and if Novacyt were concerned at all they would have withdrawn the product from CTDA certification. Do not for one moment think I condone the position Novacyt put the company in , it doesn't take a genius to research historical events. However Roche also saw fit to employ him for several years and several other well known institutions.
I cannot argue who was first off the draw with the Moneypox assays as I have insufficient info , all I know is the clades and mutations were still being established and several companies put assays on the market prior to this happening. How good are they ? I don't know.
Re dry ice , I don't pretend to know what they are telling us they have achieved , what differentiates this product is is not clear to me, I understand the usage in hot climates , the ease of transportation, but as you say , it appears to have been on the market for a while. Yet there are articles discussing the need for it in 2020 , so perhaps it is me who doesn't understand.